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ABSTRACT
Purification and Characterization of a Chemically Induced
Epstein-Barr Virus-Associated Deoxyribonuclease

by

Guang -Yuh Hwang, Master of Science
Utah State University, 1989

Major Professor: Joseph K.-K. Li
Department : Biology
Purification of Epstein -Barr virus-associated deoxyribonuclease (EBV-DNase)
from Raji and P3HR-1 cells treated with 12-0-tetradecanoylphorbol -13-acetate

and

sodium butyrate was performed by sequential ion-exchange column chromatography and
fast protein liquid chromatography . The enzyme activity, protein concentration, yield ,
specific activity, purification profiles, and polypeptide patterns by electrophoretic
analysis in each column purification step were determined.

The characteristics of the

partially isolated EBV-DNase were demonstrated by the enzyme activity, DNA binding
affinity, and inhibition by the nasopharyngeal carcinoma patient sera and rabbit
polyclonal antibodies against the partially purified EBV-DNase. A nonisotopic assay was
developed as a new method in detecting the nuclease.
homogeneity by FPLC .
determined

by

EBV-DNase was purified to

The molecular weight of the EBV-DNase was 58 KDa as

sodium

dodecylsulfate

polyacrylamide

gel

electrophoresis,

immunostaining, and radioimmunoprecipitation using nasopharyngeal carcinoma patient
sera and rabbit polyclonal antibodies.
(46 pages)

INTRODUCTION

Epstein-Barr virus (EBV), a member of the human gamma-herpesvirus family,
is a B-lymphocyte-transforming virus that causes infectious mononucleosis (IM) (15,
30) . Furthermore, there is strong evidence that EBV, as a human carcinogenic agent,
causes African Burkitt's lymphoma (BL) (13) and nasopharyngeal carcinoma (NPC)
(22) within specific races of people.

The association of EBV to these two cancers is

supported by the evidence that EBV genomes are found in BL and NPC tumor tissues of
infected patients (I 2) .

These two types of cancer also have high malignancy and

mortality rates as follows : BL is an endemic malignancy affecting mainly children in
East Africa and New Guinea, while NPC is the most common malignancy in Southeast Asia.
No specific reason has been found for the susceptibility of these populations, but it
appears to involve both genetic and environmental factors (36).
EBV, as do other herpesviruses , has a biological property of inducing latent and
persistent infection to the mature 8-lymphocytes.

The EBV target cells are mainly

terminally differentiated cells that have receptors for complement binding and
synthesize all of the different classes of the immunoglobulin heavy

and light chains

(33). The virus enters the host cell by fusion with the cell membrane. Viral DNA may
be expressed or exist intracellularly in an unexpressed state known as latency that can
be chemically activated to express. Upon activation by inducing agents, the viral DNA is
transcribed and replicated in the nucleus, and the viral mRNAs are translated in the
cytoplasm. The translation products then return to the nucleus where the nucleocapsid
is assembled.

The capsids acquire an envelope from the outer lamella of the nuclear

membrane during assembly.

The EBV viral antigens expressed during the latent and

replicative cycles include the Epstein-Barr nuclear antigen (EBNA), lymphocytedetermined membrane antigen (LYDMA), viral capsid antigen (VCA), membrane antigen
(MA), and early antigens (EA). The EBNA is expressed in EBV-immortalized human
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lymphocytes and, thus, may play an important role in immortalization (16) . The
LYDMA, demonstrated using in Wl:Q tests of cell-mediated cytotoxicity, is distinguished
from viral membrane antigens (MA) that are found on the surfaces of cells synthesizing
virions and are also components of the virion envelope (34). The VCA is found within
the cells which are producing viruses . Patients with NPC have high antibody titers to
EBV-VCA. The major approach in the study of the epidemiology of EBV infections is
detection of the antibody to EBV-VCA (17) . The MA, which is found on the cytoplasmic
membranes of the cells that are producing virions , is also responsible for eliciting
virus-neutralizing antibodies (10).

Early antigens are a group of nonstructural

components whose synthesis does not require viral DNA synthesis.
synthesized when an

infected

They can be

lymphoid cell is spontaneously triggered into viral

replication or when the viral replicative cycle is induced by exogenous stimuli such as
phorbol esters or sodium butyrate (SB) . The functions of the proteins represented in
the early antigen complex are still unknown but are likely associated with the enzymes
that are required for viral DNA replication (31) .
Three virus-encoded enzymes, including DNA polymerase (DP) (20), thymidine
kinase (TK) (11), and deoxyribonuclease (DNase) (8), involved in viral replication
have been identified. The presence of serum antibody of the lgA type to EBV-VCA is the
basis of a screening test for the detection of NPC . However, it is not sensitive enough to
detect the early EBV infection. Patients with BL, IM, and NPC have elevated levels of
entibody to early antigens, which appears to be evidence of ongoing viral infection .
High-titer antibodies to the EBV-DNase have been detected and proved to be a sensitive
epproach for the medical diagnosis of the early detection of EBV infections (4, 5).
Although the complete genome of EBV has been cloned and sequenced, the
ralationship between the viral products and their respective genes is still unknown
(18). In order to unravel the mystery of EBV latency and its induction, a more detailed

understanding of the viral enzymes involved in DNA replication is required.

The
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characterization and identification of the chemically induced EBV-associated DNase have
been partially determined

with respect to substrate specificity, strong divalent cation

requirement (Mg2+), alkaline pH optimum {pH 8.3),

and high salt resistance (8, 35,

9, 6) . However, EBV-DNase has not been purified to homogeneity. Thus, reports on
the determination of the molecular weight (M .W.) of the EBV-DNase are quite
controversial (see Table t ). This conflict

may be caused by the differential production

of EBV-DNase(s) induced in different cell lines (20 , 8, 32) or by the presence of an
EBV-DNase-associated protein , such as EBV-DNA polymerase (7).

Table t . Summary of the known molecular weight of EBV-DNase

Inducing agents

Cell lines

M.W.

Methods of

References

Determination

None

895 - 8
P HR -1
3
Raji

60 KDa

SDS-PAGEa

Clough , 1979.
( 8)

120 KDa

TPA

Tan et al. , 1982.
(35)

Raji

4.0

s

Sedimentation

Ooka et al., 1984.
(32)

SB

70 KDa

Gel filtration

Kallin et al., 1985.

( 2 0)
a Principal peptide bands of 60 KDa and 120 KDa were present, as well as several

bands of lower molecular weights in the range of 30 KDa.
6 TPA stands for 12-0-1etradecanoylphorbol-13-acetate and SB stands for sodium
butyrate .
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Procedures to purify EBV-DNase by sequential column chromatography have
been described (8, 35, 9). Because of difficulties in propagating EBV in large amounts,
as well as poor recovery and the instability of EBV-DNase, it is necessary to induce
very large numbers of cells in order to obtain sufficient amounts of enzyme for
purification. Raji and P3HR-1 (see Table 2) cells that are latently infected with EBV
exhibit increased expression of EBV-DNase activity when treated with TPA (37) and SB
(32).

TPA is a diterpene ester, known as a tumor-promoting agent that induces the

gene expression of oncogenic herpes viruses in persistently infected cells (38). SB is a
differentiation inducer that has been found to increase the number of virus-producer
cells to a dramatic extent in the EBV-carrying cell lines (25).

Table 2. TPA-induced EBV-transformed cell linesa
Cell lines

Origin

% cell stained specifically for

viral antigen (VCA,EA)

Raji

African Burkitt's lymphoma

control

5d TPAb

<0.01

1 2.2

9 .1

74.3

(EBV-nonproducer)
African Burkitt's lymphoma
(EBV-producer)

a The data was adapted from Zur Hausen et al., 1978 (38).

b The cells were stained with a human EA+ VCA+ serum (1 :40 dilution) 5 days
alter the addition of 20 ng/ml of TPA.

The frequency and levels of antibody against EBV-DNase in NPC-patient sera are
much higher than in sera of healthy individuals or individuals with

IM or BL.

Thus,

use of purified EBV-DNase may aid in the early diagnosis of NPC.

Furthermore, the
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identification of the M.W. and amino acid sequence of purified EBV-DNase will be useful
in the determination of the viral coding region as well as the molecular aspects of EBV.
Therefore, the objectives of this thesis were to purify the chemically induced
EBV-DNase to homogeneity, to determ ine its M.W.• to investigate some of the
biochemical characteristics of the purified EBV-DNase. and to produce polyclonal antiEBV-DNase sera for immunological determinations and subsequent experimentation .

6
MATERIALS AND METHODS

Chemical induction in Raji and P3HR-1 cell lines.

Lymphocyte

cell

lines have been previously described (14) . Raji (a Burkitt's tumor nonproducer B-cell
line) and P3HR -1 (a Burkitt's lymphoma-derived cell line) cells were maintained
between 5 x 105 to 1 x 106 cells/ml in RPMI-1640 (GIBCO, Grand island, NY) medium
containing 10% heat-inactivated fetal calf serum (Hyclone, Logan, UT).
P3HR-1 cells were seeded at 106 cells per ml in culture medium.
Louis, MO) was added at a final concentration of 40 ng/ml.

Raji and

TPA (Sigma, St.

SB was added at a final

concentration of 4 mM. The culture was incubated at 37<lC for 64 -72 hrs.

Preparation of Escherlchja ~ [lHJ-DNA.

Native double-stranded L

kQ}1 [3H]-DNA was prepared from the thymine-requiring strain.

The bacteria

were

grown in 2 liters of a minimal medium containing 40 mM K2HP04, 22 mM KH2P04, 2
mM Na3C6H507, 0.4 mM MgS04.H20, 7 mM (NH4)2S04, 0.25% glucose (w/v), 2.5
11M

unlabelled thymine, and 500 11Ci of 3H -thymine (NEN, Boston, MA).

was isolated by the procedure of Marmur (26) . Isolated

[3H]-DNA

£. !<QJ1 [3H]-DNA was used as

substrate in EBV-DNase enzyme activity assays.

EBV-DNase assay. EBV-specific DNase enzyme activity was measured by the
release of acid-soluble nucleotides from double-stranded [3H]-DNA by the method of
Hoffman and Cheng (18).

Briefly, each reaction

Tris (pH 8.3), 10 mM MgCI2, 10 mM

solution contained 0.2 ml of 50 mM

13-mercaptoethanol, and 1.2 11g of £!<Qfi [3H]-

DNA. The enzyme assay mixture contained 10 111 of enzyme preparation plus 190 111 of
the reaction solution.

The assay was incubated

at 37°C

for 40

min with constant

shaking. Following incubation, calf thymus DNA (Sigma, St. Louis, MO) was added as a
carrier to a final concentration of 0.25 11g per mi.

Trichloroacetic acid (TCA)

(Mallinockrodt, Paris, KY) was added to a final concentration of 5% in each assay to
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precipitate the undigested DNA substrate. Each reaction tube was kept in ice for 20 min.
Following

centrifugation

Hicksville, NY). 200

~I

at 3,000 rpm for 10 min (SAVANT, model PH40 -11,
of the acid-soluble nucleotide was removed from the

supernatant for scintillation counting in a Beckman LS-7800 liquid scintillation
counter .

.E. {;Q}1 DNase I was used as a positive control in this assay.

Purification of the chemically induced EBV-DNase.

The procedures of

Goodman et al., 1978 (14) for harvesting the cells, making the crude cell extracts, and
performing

DEAE-cellulose,

phosphocellulose,

and

chromatography were followed with minor modifications:

DNA -ce llulose

column

The cell extracts from 10

liters of Raji cells were centrifuged at 12,000 x g for 20 min in a SS-34 rotor in a
Sorvall RC -2B centrifuge, and the resulting supernatant was loaded onto

a DEAE-1-

cellulose column (2 x 5 em) that was equilibrated and eluted with 300 mM potassium
phosphate

buffer

(pH

8.3)

containing

20%

glycerol

(v/v),

1 mM

phenylmethanesulfonylfluoride (PMSF) (Sigma, St. Louis, MO) , 1 mM EDTA, and 2 mM
dithiothreitol (OTT) (Boehringer Mannheim , Kuhl Lagern, W. Germany) .

The eluted

samples in the peak fractions were pooled, dialysed against 20 mM potassium phosphate
buffer (pH 8.3) at 4oc, and centrifuged at 12,000 x g for 20 min (Sorvall, SS-34
rotor).

The dialysate was loaded onto another DEAE-11-cellulose column (2 x 5 em).

The EBV-DNase was eluted with a linear gradient of 50-300 mM potassium phosphate
buffer (pH 8.3).

Fractions of 3 ml from the DEAE-11-cellulose column were collected

and assayed. Fractions containing DNase activity were pooled and dialysed against 1 liter
of 20 mM potassium phosphate buffer (pH 8.3) for 15 hrs at 4oc . Dialysed DEAE-11cell ulose DNase peak fractions were loaded onto a phosphocellulose column (1 .5 x 5 em).
A gradient elution from 50 to 300 mM potassium phosphate buller {pH 8.3) was used.
Fractions of 2 ml were collected and the enzyme activity was determined. The fractions
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containing the EBV-DNase were pooled and dialysed against 1 liter of 20 mM potassium
phosphate buffer (pH 8.3) for 15 hrs at 4oc .
Dialysed phosphocellulose DNase peak fractions were loaded onto a DNA-cellulose
column (1 .2 x 1 em) . A gradient elution of 50 to 400 mM potassium phosphate buffer
(pH 8.3) was used.

Fractions of 1 ml were collected and the enzyme activity was

determined. The fractions containing the EBV-DNase were pooled and dialysed against 1
liter of dialysis buffer (20mM Tris-buffer (pH 8.3) , 40% glycerol (v/v) , 2 mM DTT,
2 mM PMSF) at 4oc ovenight. The dialysed EBV-DNase was stored at -7ooc until used.

EBV-DNase neutralization assay.

Neutralization of EBV-DNase activity by

human NPC sera (provided by Dr. J . F. Chiou , Taipei, and Dr. R. S. Tan , Beijing) and
rabbit polyclonal was assayed as described by Cheng et al. (5) . After incubation at room
temperature for 20 min , the immunocomplexes were pelleted by centrifugation at
3,000 rpm for 10 min in a swinging bucket rotor (SAVANT, model PH40-11 ,
Hicksville, NY), and the supernatant was examined for DNase enzyme activity( described
above) .

SDS-PAGE, blotting , and immunostaining.

Sodium

dodecylsulfate

polyacrylamide gel electrophoresis (SDS-PAGE) was carried out according to Laemmli
(23) using 10% gels.

After electrophoresis, gels were silver stained by the method of

Merril et al. (29).

Proteins were transferred to nitrocellulose paper by the method of

Bowen et al. (3) .

lmmunostaining of proteins on nitrocellulose paper was carried out

according to Legocki and Verma (24) by using alkaline phosphatase-conjugated goat
antibodies (2) .
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EBV-DNase determination by agarose gel electrophoretic analysis.
Specific EBV-DNase nucleolytic reactions were carried out as described in
DNase assay.

the EBV-

The reaction solution contained 50 iJ.I of 50 mM Tris (pH 8.3),

10 mM

MgCI2, 10 mM B-mercaptoethanol, 2 IJ.g of the BstE n-digested Lambda-DNA (Biolabs,
Beverly, MA} , and 4 IJ.g of the partially purified EBV-DNase. The mixture was incubated
in the presence and absence of NPC patient sera in a 37<>C water bath with constant
shaking .

Five microliters (iJ.I) of the reaction mixture containing 0.2 llg of BstE n-

digested Lambda-DNA was removed at different time intervals and was put into a precooled microcentrifuge tube for agarose gel electrophoretic analysis.

The BstE 11-

digested Lambda-DNA was analysed in 1% horizontal agarose gel in TBE buffer (89 mM
Tris-borate, 89 mM boric acid, 2 mM EDTA, 0.5 llg of ethidium bromide per ml, pH
8.0) (28) .

.1;.,.~

DNase I was used as a positive control, and BstE II·digested Lambda-

DNA in the absence of enzyme preparation was used as a negative control.

Gel-retardation analysis of the DNA-cellulose peak fraction B.
DNA-binding

The

affinity of the partially purified EBV-DNase was determined in

polyacrylamide gel electrophoresis (PAGE) . The DNA-cellulose peak fraction was used
as enzyme to digest Hind III-digested Lambda-DNA (Biolabs, Beverly, MA) . DNA binding
was performed at 4oc in the absence of Mg2+ , which is the required cation in this
nucleolytic reaction . The reaction solution contained 50 iJ.I of 50 mM Tris (pH 8.3), 10
mM B-mercaptoethanol, 0.2 llg of the Hind III-digested Lambda-DNA, and 8 IJ.g of the
partially purified EBV-DNase. The mixture was analysed by the PAGE at 4oc followed
by 40 min of nucleolytic reaction. The same amount of the EBV-DNase in the absence of
Hind III-digested Lambda-DNA was used as negative control.

Radioiodination

of

the

DNA-cellulose

peak

fraction

B.

The

chloramine-T procedure was used for radioiodination of proteins (19). The iodination
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was carried out at room temperature . DNA-cellulose samples were incubated with 0.5
mCi of Na125J (ICN, Costa Mesa, CA) and 160 !lg of chloramine-T (Sigma, St. Louis,
MO) in 400 !11 of 50 mM potassium phosphate buffer, pH 8.3. Glycine was added to a
final concentration of 15 !lgiml after a 1 min of iodination period to prevent any
subsequent iodination. Separation of labelled EBV-DNase from unincorporated label was
carried out by gel filtration using a column containing 30 mg of 48 dextran (Bio-Rad,
Richmond, CA). Precipitation of iodinated EBV-DNase was done by mixing the labelled
EBV-DNase with TCA to a final concentration of 10% at 4°C overnight.

Production of rabbit polyclonal antibodies .

The partially purified EBV-

DNase from the DNA-cell ulose peak fractions (300 !lg) was used for immunization to
produce

rabbit antiserum to the EBV-DNase . The rabbit was immunized by repeated

intradermal injection .

The first inoculum consisted of 0.25 ml of complete Freund

adjuvant mixed with 0.25 ml of the antigen preparation (1 00 !lg) .

The animal was

boosted with incomplete Freund adjuvant once a month and bled from the ear 1 week
after each booster. Pre-i mmuned serum was collected from the rabbit 1 week before
immunization began. Sera from the injected rabbit were tested by dot immunostaining
with partially purified EBV-DNase as antigen and screened for neutralization antibodies
to the viral DNase by a neutralization assay.

Radioimmunoprecipitation

(RIP).

The iodinated DNA -cellulose peak

fraction B was pre-absorbed by the EBV-negative human serum (provided by NIH) or
pre -immuned

rabbit

serum

before

immunoprecipitation .

supernatants were assayed for nuclease activity.

The

pre-absorbed

lmmunoprecipitations were carried

out for 18 hrs at 4oc by using rabbit anti -DNase sera and human NPC sera.

The

resulting complexes were precipitated by the addition of protein A-sepharose (Sigma ,
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St. Louis , MO), followed by incubation at 4oc for 30 min with constant shaking.
Protein A-sepharose and adhering immune complexes were collected by centrifugation
and then washed 6 times in phosphate buffer saline (PBS), pH 7.3. Protein A-sepharose
was separated from immune complex by boiling for 10 min in SDS-PAGE sample buller
(50 mM Tris, pH 7.3, 1% SDS (w/v), 20% glycerol (v/v), 5% B-mercaptoethanol
(v/v) , and 100 11giml of Bromphenol Blue) .

The protein A-sepharose was then

pelleted, and the supernatant was removed and analysed by SDS-PAGE and
autoradiography. The dried gel was exposed to Kodak X-AR film at -2ooc .

FPLC

purification

of

DNA-cellulose

peak

fraction

B.

Partially

purified EBV-DNase from the peak fraction of the DNA-cellulose column was further

a (HR 5/5) column using a Pharmacia high-resolution FPLC
Mono a column was equilibrated with 10 mM sodium acetate buller,

fractionated by a Mono
system (21). The

pH 6.0, and a total of 40 119 of protein was loaded onto the column . The column was
washed with 10 mM sodium

acetate buller, pH 6.0, and proteins were eluted with a

linear gradient containing 10-1000 mM sodium acetate buller, pH 6.0. The flow rate
was 1 mVmin, and 1 ml fractions were collected . The nuclease activity of each fraction
was determined and neutralization by human NPC sera was also assayed. The peak
fractions with nuclease activity and neutralization activity were pooled, concentrated by
TCA precipitation for three days, and then analysed by SDS-PAGE.
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RESULTS

Purification of the chemically Induced EBV-DNase in P3HR-1

and

Raji cells. The combination of diterpene ester promoter of mouse skin tumors, TPA,
and cell differentiation inducer, SB, was used to induce DNase activity in the EpsteinBarr virus-producer cell line P3HR -1 (37} and the Burkitt's tumor nonproducer Raji
cell line (32}. The chemically induced EBV-DNase from Raji cell lysates was partially
purified by sequential ion-exchange column chromatography , and the profiles of each
purification step are shown in Figs. 1, 2,

and 3.

Each peak fraction could

be

neutralized by human NPC sera. The chemically induced EBV-DNase in Raji cell extracts
eluted from DEAE-n-cellulose at 125 mM (Fig . 1}. phosphocellulose at 225 mM (Fig.
2}. and

DNA-cellulose at 250 mM potassium phosphate buffer (Fig. 3} . Based upon

these elution profiles and neutralization by human NPC sera, the chemically induced
EBV-DNase is different from the cellular DNase (8, 35, 7} .
In Tables 3 and 4 are summarized the total enzymatic activity, specific activity,
yield, and purification in each of the column chromatographic steps.

The specific

enzyme activity of the partially purified DNase increased 70-fold over that of the crude
extracts and represents a 5.4% recovery in induced-Raji cells (Table 3} and a 2.1%
recovery from induced-P3HR-1 cells

(Table 4) .

The SDS-PAGE analysis of samples from different steps of EBV-DNase
purification in Raji and P3 HR-1 cell lines was visualized by silver staining .

The

results are shown in Figs. 4 and 5. The DNA-cellulose samples purified from Raji cells
contained five major bands with the M.W. of 50 kilodaltons (KDa}, 52 KDa, 58 KDa, 66
KDa, and 80 KDa (Fig. 4}. However, the DNA-cellulose samples purified from P3HR -1
contained only two major proteins of 52 KDa and 58 KDa (Fig. 5} .
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chromatography purification profile of EBV-DNase .

Fractions 4 through 6 from DEAE-11-cellulose were pooled, dialysed, and then
chromatographed as described under Materials and Methods. The DNase activity
was measured by the release of acid-soluble nucleotide from

.E ~ [3H]·DNA .
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Fig . 3. DNA cellulose column ch romatography purification profile of EBV-DNase.
Fractions 10 through 12 from phosphocellulose were pooled , dialysed, and then
chromatographed as described under Materials and Methods. Peak fractions A and C
cannot be inhibited by

human NPC sera.

Peak fractions B can be inhibited by

human NPC sera. Fractions B was used in all subsequent experiments. The DNase
activity was measured by the release of acid-soluble nucleotide from £ kQJ1 [3H] DNA
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Table 3 . Purification of EBV-DNase from TPN SB-induced Raji cells"

Volume Total protein
(ml)

(mg)

Total activity Specific activity
(unit)&

(unit/mg)

Yield

Purification

(%)

Crude extract

40.0

538 .0

259 .8

0.48

100.0

1.0

DEAE-Il

24 .0

34 .5

240 .0

2.94

92 .3

6.1

Phosphocellulose

7.2

3.6

65.6

18.20

25 .2

37 .9

DNA-cellulose

1.0

0.4

14. 1

35.25

5.4

73 .4

« 10 liter of Raj i cells were induced by 40 ng/ml of TPA and 4 mM of SB for three
days.
b One unit of DNase activity was defined as that amount of activity which digests 1 Jlg of
native DNA to acid-soluble nucleotide in 10 min at 370C.

Table 4. Purification of EBV-DNase from TPNSB-induced P3HR- 1 cells"

Volume
(ml)

Total protein Total activity Specific activity
(mg)

(unit)&

Yield

(unit/ mg)

(% )

Purification

Crude extract

30.0

522 .00

141 .10

0.27

100.0

1.0

DEAE-11

23.0

28.75

121.90

4.24

86 .3

15.8

Phosphocellulose

10.0

5.10

75.60

14.28

53 .5

54.9

0.5

0.17

2 .99

17.60

2.1

65.2

DNA-cellulose

« 10 liter of P3HR-1 cells were induced by 40 ng/ ml of TPA and 4 mM of SB for two
and half days.
& One unit of DNase activity was defined as that amount of activity which digests 1 Jlg of
native DNA to acid-soluble nucleotide in 10 min at 370C .
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A

8

c

D

Fig . 4. SDS-PAGE of samples from the peak fractions of the three columns used in the
purification of EBV-DNase from the Raji cell extracts.

Lanes A through E are

described as follows: DNA-cellulose (lane A), phosphocelllulose (lane B), DEAEll-cellulose (lane C), cell extracts (lane D), and molecular weight standards
Lanes A through E were visualized by silver staining.

Proteins from

these peak fractions and cell extracts were used in immunoblots.

(lane E).

Proteins from

DNA-cellulose peak fraction B were used in all subsequent radioiodination and
FPLC.

I8

A

B

C

D

E

F

Fig. 5. SDS-PAGE of samples from the peak fractions of the three columns used in the
purification of EBV-DNase from the P3HR-1 cell extracts. Lanes A through Fare
described as follows:

molecular weight standard (la ne A). cell extracts (lane B).

DEAE-II-cellulose (la ne C). phosphocellulose (lane D) , and DNA-cellulose (lanes
E and F). Lanes A through F were visualized by silver staining.
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Characterization of the chemically induced EBV-ONase.

It has been

observed that human NPC sera neutralized up to 86% of the EBV-DNase activity

in

partially purified samples (5) . The presence of EBV-DNase was verified by the results
shown in Table 5. The DNase activity was neutralized up to 90% by human NPC sera and
54% by rabbit polyclonal antibodies when compared with normal human sera and preimmuned serum.
Considering the potential DNA affinity of EBV-DNase, a gel -retardation
experiment was carried out in PAGE. The DNA-cellulose peak fraction B (Fig. 3) was
mixed with Hind III-digested Lambda-DNA in test tubes at 4oc in the absence of MgCI2,
the required divalent cation in this nucleolytic reaction (8).

The large fragments of

Hind Ill-digested Lambda-DNA were retarded at the stacking gel by binding with the EBVDNase in the DNA-ce llulose samples.

The results are shown in Fig. 6.

After silver

staining, prote ins could not be visualized in the lane containing both Lambda-DNA and
partially purified EBV-DNase ; however, proteins could be seen in the lane containing
only partially purified EBV-DNase.

These results indicate that the partially purified

EBV-DNase has a DNA-binding affinity which causes non-visualized proteins at the
running gel of PAGE. Moreover, in the absence of Mg2+, the nucleolytic reaction can not
occur.
The partially purified EBV-DNase digested both native and denatured DNA to
mononucleotides (8). To determine whether restriction-enzyme-digested Lambda-DNA
could be used as substrate, and if the reaction could be visualized by staining instead of
the standard isotopic assay, the nuclease activity of EBV-DNase on BstE 11-digested
Lambda-DNA and its neutralization by human NPC sera were investigated in agarose gel
electrophoresis.

The DNA-cellulose peak fraction B (Fig. 3) was used as enzyme to

digest BstE 11-digested Lambda-DNA. The results are shown in Fig. 7. In lanes 2 to 5 of
Fig .7 it is evident that partially purified EBV-DNase digested Lambda-DNA in 1%
agarose gel in the different intervals. In lanes 6 to 14 it is evident that the nuclease
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activity of the partially purified EBV-DNase could be neutralized by the addition of
human NPC sera prior to the commencement of the 40 min nucleolytic reaction . These
results indicate that the partially purified EBV-DNase could digest Lambda-DNA. Human
NPC sera could neutralize the nuclease activity completely.

DNA digestion required

Mg2+ and the nonisotopic assay could be easily visualized.

Table 5. lnhibitiona of EBV-DNase by 1 :20 dilution of human NPC sera and rabbit
polyclonal antisera

Non·induced cell lysate

Crude extracts

Purified EBV -DNase

------------------------------------------------------------Enzyme activity&
(no serum)

340"

1807

(N)d:

2010

Normal sera

349

Human NPC sera

204

Enzyme activity
(no serum)

340

Pre-immuned sera

253

(0)

1721

Rabbit antisera

234

(31)

641

a Inhibition was defined as that

(40)

4196

(N)

408 (77)

3580±.267 (14)
422±.23

(90)

3204

1583

(N)

3090±.31

(60)

1483±.196

(4)
(54)

amount of decreased activity of EBV-DNase in the

presence of each corresponding antibody.
b Nuclease activity assays were performed as described under Materials and Methods.
c Radioactivity in cpm as determined by scintillation counting.

<L Values in parentheses represent % of inhibition, and N in parentheses represent no
inhibition.
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A

B

c.

D

Fig. 6. Determination of the DNA-binding affinity and the Mg2+ requirement of the
partially purified EBV-DNase in a 12.5% PAGE.

Molecular weight standards

(lane A), DNA-cellulose peak fraction B mixed with Hind III-digested LambdaDNA in the absence of the divalent cation (Mg2+) at 4oc (lane B). DNA-cellulose
peak fraction B (lane C), and Hind III-digested Lambda-DNA (lane D).
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Fig.?. Determination of the partially purified EBV-DNase activity in a 1% agarose gel.
Each lane contains 0.2 11g of BstE 11-digested Lambda-DNA. Lanes 1 through 15 are
described as follows:
BstE 11-digested Lambda-DNA which has 14 fragments with different sizes (lane
1), BstE n-digested Lambda-DNA digested by EBV-DNase for 20, 40, 60, and 80
min (lanes 2 to 5, respectively ), BstE 11-digested Lambda-DNA digested by EBVDNase for 20, 40, 60, and 80 min of a nucleolytic reaction to which a 1/20
dilution of human NPC sera had been added (lanes 6 to 9, respectively ), different
dilutions (1/1 0, 1/ 20, 1/4 0, 1/60, 1/8 0) of

human NPC sera were added

prior to a 40 min nucleolytic reaction (lanes 10 to 14, respectively ), and BstE
IJ-digested Lambda-DNA by£. coli

DNase I (lane 15).

23
Determination of the M.W. of the chemically induced EBV-DNase .
Due to the low concentration of protein in the column eluants, the volumes of the peak
fractions were reduced prior to protein analysis by SDS-PAGE. Despite these efforts,
the concentrated nuclease-active fraction from DNA-cellulose chromatography produced
only a faint protein banding pattern in SDS-PAGE. The results are shown in Figs. 4 and
5. However, the M.W. of chemically induced EBV-DNase has been reported (20 , 8, 32)
with a M.W. ranging between 70 KDa and 58 KDa (see Table 1).
Three methods were used to determine the M.W. of the chemically induced EBVDNase from TPNSB-induced Raj i cells . They were immunostaining, radioimmunoprecipitation (RIP),

and the ion-exchange chromatography using

FPLC. The

immunostaining data are shown in the western blots using human NPC sera (Fig. 8) and
rabbit polyclonal antibodies (Fig . 9) . The results show a different reaction of human
NPC sera and rabbit antisera to the antigen mixtures of different stages of purification.
The human NPC sera showed broad reactions to the antigens in the range of 45 KDa and
66 KDa. The rabbit antiserum showed a strong reaction to 58 KDa and 52 KDa proteins,
even in the DNA-cellulose sample.
The small amount of EBV-DNase could not be detected in western blots (Fig. 8,
lane A) .

Radioimmunoprecipitation was applied for enhancing the sensitivity in

detecting the EBV-DNase. Equal amounts of DNA-cellulose samples were iodinated and
then immunoprecipitated with the human EBV-negative sera , human NPC sera, preimmuned rabbit sera, and the rabbit polyclonal antisera. The resulting complexes were
analysed by SDS-PAGE. An autoradiogram is shown in Fig. 10. To further reduce the
non-specific background, iodinated samples were pre-absorbed with the human EBVnegative sera or pre-immuned rabbit sera, and the pre-absorbed supernatants were
then

immunoprecipitated by human NPC sera or rabbit polyclonal antiserum.

results are shown in Fig. 11 .

The

24
The third approach to determine the M.W. of the EBV-associated DNase was to
further purify this enzyme to homogeneity by FPLC . FPLC purification profile is shown
in Fig. 14. Both FPLC peak fraction A and B had a nuclease activity, but only peak A was
neutralizable by human NPC sera (Table 6). The specific activity of the peak-A fraction
was 185 units/mg and a purification of 385-fold was achieved, but the yield was only
1.7% (Table 7). SDS-PAGE analysis of FPLC peak fraction A and B is shown in Fig.13.
The results showed that a small amount of the chemically induced EBV-associated DNase
that could be neutralized by human NPC sera was purified to the homogeneity, as
determined by silver staining (Fig.13, lane A) and had a M.W. of 58 KDa.

The two

proteins with M.W. of 58 KDa and 52 KDa present in fraction B (Fig .13, lane D) also
had nuclease activity that was not neutralized by human NPC sera (Table 6).

These

results indicate the potential presence of two different DNases in the TPA/SB-induced
Raji cell extracts.
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Fig. 8. Western immunoblot of polypeptides from the peak fractions of the three columns
and TPNSB-induced Raji cell extracts bound with human NPC sera at 1:100
diluton

in

TBST

buffer.

DNA-cellulose

peak

fraction

B

(lane

A).

phosphocellulose (lane B), DEAE-II-cellulose (lane C), and cell extracts (lane
D) were immunostained by alkaline phosphatase-conjugated goat anti-human
lgG.

Molecular weight standards (lane E) and 58 KDa pre-stained protein

marker (pyruvate kinase from chicken muscle ) (lane F) were stained by
Amido Black staining.
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A

B

c

D

E

F

-92

-66

-45

Fig. 9. Western immunoblot of polypeptides from the peak fractions of the three columns
and TPAJSB-induced Raji cell extracts bound with rabbit polyclonal antisera at
1:1 DO diluton in TBST buffer.

Cell extracts (lane A), DEAE·Il-cellulose (lane

B), phosphocellulose (lane C), and DNA-cellulose peak fraction B (lane D) were
immunostained by alkaline phosphatase-conjugated goat anti-rabbit lgG.

58

KDa pre-stained protein marker (lane E) and molecular weight standards (lane
F) were stained by Amido Black.
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A

B

c

D

-sa

Fig . 10. Autoradiogram of radioimmunoprecipitations of the iodinated EBV-DNase from
the DNA-cellulose peak fraction by 1 :20 dilution of each of the corresponding
antibodies: EBV-negative human sera (lane A). human NPC sera (lane B), preimmuned rabbit sera (lane C), and rabbit polyclonal antisera (lane D). The
adhering immune complexes were pelleted by protein A-sepharose and analysed
by 10% SDS-PAGE as described under Materials and Methods.
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A

B

Fig. 11. Autoradiogram of radioimmunoprecipitations of the iodinated EBV-DNase from
the DNA-cellulose peak fraction 8 by 1:20 dilution of human NPC sera (lane A)
and rabbit polyclonal antisera (lane B) . The iodinated DNA-cellulose peak
fraction 8 was pre-absorbed by the human EBV-negative sera or pre -immuned
rabbit sera. The adhering immune complexes were pelleted by protein Asepharose and analysed by 10% SDS-PAGE as described under Materials and
Methods.
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Fig . 12. FPLC Mono Q column chromatography of the DNA-cellulose peak fraction B. The
DNA-cellulose peak fraction

B containing

high

nuclease activity and

neutralizable activity by human NPC sera were run through a Mono Q column
equilibrated in 10 mM sodium acetate buffer (pH 6.0) and eluted with a 10 to
1000 m M sodium acetate linear gradient. Poo led peak fractions were
precipitated in 15% TCA for 3 days at 4oc and then analysed by SDS-PAGE.

30

Table 6. Inhibition" of EBV-DNase from FPLC fractions by 1:20 dilution of human NPC
sera
Fraction no.

B

A

10

9

DNase activity&

81 7c ±.8 1

507±.334

NPC sera added

517

429

4158±.282

1498±.73

621±.295 (85}<! 2437±.154 (N}

a Inhibition is defined as that amount of decreased activity of EBV-DNase in the presence
of 1 :20 dilution of human NPC sera.

b Nuclease activity assays were performed as described under Materials and Methods.
c Radioactivity in cpm as determined by scintillation counting .
d:

Values in parenthesis represent % of inhibition, and N in parenthesis represent no
inhibition.

Table 7. Purification of EBV-DNase from DNA-cellulose peak B fraction by FPLC

Volume
(ml)

Total protein
(mg)

Total activity
(unit)"

Specific activity
(unit/mg)

Yield Purification
(%)

Crude extract

40 .0

538.0

259 .8

0.48

100 .0

1.0

DNA-cellulose

1.0

0 .4

14 . 1

35 . 25

5 .4

73 . 4

FPLcb

2.0

0 .0244

4.5

185.25

1.7

385 . 9

a One unit of DNase activity is defined as that amount of activity which digests 1

11g of

native DNA to acid-soluble nucleotide in 10 min at 370C .
b Peak fraction 8 containing 40 llQ of partially purified EBV-DNase was loaded onto a
Mono Q (HR 5/5} column .
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A

C

D

Fig.13. SDS-PAGE of samples from FPLC peak fractions.
visualized by silver staining.
Lane A: peak A fraction of Mono Q column .
Lane B: Molecular weight standards.
Lane C: 58 KDa protein marker.
Lane D: peak B fraction of Mono Q column .

Lanes A through D were
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DISCUSSION

The data presented in this thesis show that an EBV-DNase can be chemically
induced by TPNSB in Raji and P3HR-1 cell lines.

Induced cells exhibit increased

expression of the EBV-associated DNase as compared with the non-induced Raji cells and
P3HR-1 cells. When the chemically induced Raji and P3HR-1 cells express EBV-DNase
activity, this is an indication that the cells are undergoing active EBV DNA replication
after latency activation . Ooka et al. demonstrated that the chemically induced DNase
activity in Raji cells can be neutralized by the EBV-positive sera, mainly by sera from
NPC patients (32). The chemically induced EBV-DNase activity was shown to be 90%
neutralizable with human NPC sera but not with EBV-negative human sera.
Furthermore, the rabbit antisera can also partially inhibit 54% of the EBV-DNase
activity with the same property as human NPC serum does (Table 5).
The partial purification of the chemically induced EBV-associated DNase from the
cell extracts was accomplished by sequential ion-exchange column chromatography. The
viral nuclease activity from Raji cell extracts eluted from DEAE-n-cellulose at low salt
concentration, and from phosphocellulose and DNA-cellulose at high salt concentration
(Figs. 1, 2, 3).

These results are

similar to those reported by Clough (9).

After

DEAE-cellulose, phosphocellulose, and finally DNA-cellulose chromatography, the
nuclease showed a net purification of about 70-fold in both cell lines.

The yield was

about 5.4% of the total EBV-induced enzyme in the Raji crude extracts but only 2.1%
from P3HR-1 cell lysate (Tables 3, 4).
The chemically induced EBV-DNase, like those induced by herpes simplex virus
types 1 and 2, has characteristics of an optimum alkaline pH, a strong requirement for
Mg2+, and is unstable when highly purified (18) . Clough demonstrated that the EBVDNase isolated from P3HR-1 cells utilizes both single- and double-stranded DNA as
template , reducing both to monophosphonucleotides (8).

All of these characteristics
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were confirmed by the investigation of the partially purified EBV-DNase from both
TPNSB-induced Raji and P3HR-1 cells .
The partially purified EBV-DNase exhibits a DNA-binding affinity as shown in a
gel retardation analysis (Fig . 6).

These data also confirm that the requirement of the

divalent cation (Mg2+) is important in its nucleolytic reaction .

Furthermore, the

partially purified EBV-DNase can use the BstE 11 -digested Lamda-DNA as substrate for
digestion, and the nuclease activity can be completely neutralized by human NPC sera
(Fig . 7). The kinetics of digestion by EBV-DNase can be visualized by simple staining,
and this nonisotopic assay provides an alternative method for the standard isotopic assay
for EBV-DNase determination .
The partially purified EBV-DNase is different from the cellular DNase based
upon elution profile, optimum alkaline pH (pH 8.3), divalent cation requirement,
substrate specificity, and neutralization by sera from NPC patients (8 , 35, 7).

Due to

the limited recovery and stability of partially purified sample , the M.W. of EBV-DNase
has not been determined accurately.

However, the partially purified EBV-DNase has

been reported to have a sedimentation coefficient of about 4S (Svedberg unit) (9 , 32).
A globular protein of this sedimentation coefficient value would have a M.W. of
approximately 58 KDa (27). SDS-PAGE analysis of EBV-DNase purified from Raji and
P3HR-1

cell lines showed two similar polypeptides, 58 KDa and 52 KDa in the DNA-

cellulose peak fraction (Figs. 4, 5). The M.W. of 58 KDa supports the assignment of the
size of EBV-DNase with 4S. The 52 KDa protein can be either a second EBV-DNase or a
host DNase contaminant.
Studies from immunostaining of western blots show that (i) the anti-EBV DNase
rabbit antisera strongly reacted with the 52 KDa and 58 KDa proteins of the DNAcellulose samples (Fig. 9), and (ii) the human NPC sera reacted with several proteins
including the 58 KDa and 52 KDa proteins (Fig. 8). This information indicates that 58
KDa and 52 KDa could be the M.W. of the chemically induced EBV-DNase.
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Studies from radioimmunoprecipitation using rabbit anti-DNase sera , preimmuned rabbit sera, the EBV-negative, and EBV-positive human sera show that the
rabbit antisera and human NPC sera precipitated a

58 KDa protein (Figs. 10, 11 ).

There was no indication for specific precipitation of a protein with similar M.W. by the
rabbit pre-immuned serum and human EBV-negative serum . These studies indicate that
the chemically induced EBV-DNase has a M.W. of 58 KDa.
EBV-DNase was also purified to apparent homogeneity by FPLC (Fig.13} , and a
385-fold purification was achieved. The specific activity of the highly puried enzyme is
185 units/mg . However, the final yield of this enzyme was only about 1.7% of the total
EBV-DNase in the Raji cell extracts (Table 7) .

Two nuclease activity peaks were

identified in FPLC (Fig.12). Peak A had nuclease activity and was neutralizable by NPC
patient sera. SDS-PAGE analysis of peak A had a single protein band with a M.W. of 58
KDa (Table 6).

Peak B appeared to contain two proteins, 58 KDa and 52 KDa, but the

associated nuclease activity was not neutralizable by human NPC sera (Fig.13).
suggesting the presence of a second EBV-DNase or representation of a co-purified host
DNase contaminant . These studies strongly suggest that the chemically induced EBVDNase has a M.W. of 58 KDa.
The chemically induced
nuclease activity, but

Raji and P3HR-1 cells exhibit increased EBV-DNase

non-induced Raji and P3HR-1 cells do not show this increase.

This partially purified EBV-DNase is neutralized by human NPC sera and rabbit
polyclonal antibodies but can not be neutralized by EBV-negative human sera or preimmuned rabbit sera.

The chemically induced EBV-DNase purified by sequential ion-

exchange column chromatography has the following characteristics: an optimum alkaline
pH {pH 8.3} , a high salt resistance in EBV-DNase activity assay, and ability to use
Lambda-DNA as substrate.

By using three different approaches, which include

immunostaining , radioimmunoprecipitation and FPLC, the M.W. of the chemically
induced EBV-DNase has been determined to be 58 KDa.

This 58 KDa protein that was
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purified to homogeneity shown as a single protein species in SDS-PAGE analysis has the
highest EBV-DNase activity and

is inhibited by both polyclonal rabbit antisera and

human NPC sera. In previous reports , the determination of the M.W. of EBV-DNase was
based on enzyme samples which had not been purified to homogeneity (20, 8, 35, 32) .
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